multistar 3 up (Vygon Company)
90
Structured Review
Vygon Company
multistar 3 up
Multistar 3 Up, supplied by Vygon Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multistar/multistar+3+up/pmc11591004-2-0-4
Average 90 stars, based on 1 article reviews
Multistar 3 Up, supplied by Vygon Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multistar/multistar+3+up/pmc11591004-2-0-4
Average 90 stars, based on 1 article reviews
multistar 3 up - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly. Article Snippet: 0196-6553/$36.00 Copyright 2015 by the Associa http://dx.doi.org/10.1016/j.ajic.2015.08.014 Background: The objective of this study was to compare the incidence of catheter-related bloodstream infection (CRBSI) with the use of second-generation chlorhexidine-silver sulfadiazine (CHSS)e impregnated catheters, rifampicin-miconazole (RM)eimpregnated catheters, and standard catheters.. Methods: Retrospective study of patients admitted to an intensive care unit who received CHSS, RM, or standard catheters in femoral venous access.. Results:We diagnosed 18 CRBSIs in 245 patients with standard catheters in 2,061 days, zero CRBSI in 169 patients with CHSS-impregnated catheters in 1,489 days, and zero CRBSI in 227 patients with RM-impregnated catheters in 2,009 days. Article Title: The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Article Snippet: The catheters used were the Article Title: Lower associated costs using rifampicin-miconazole‒impregnated catheters compared with standard catheters. Article Snippet: oi:1 Previous cost-effectiveness analyses found that antibiotic-impregnated catheters decrease the incidence of catheter-related bloodstream infection (CRBSI) as well as the costs related to central venous catheter (CVC) use, including increased hospital length of stay.. The effect varied greatly among the studies, however.. In this retrospective cohort study, compared with standard catheters, the use of rifampicin-miconazole–impregnated catheters was associated with lower CRBSI incidence and immediate CVCrelated costs (taking into account only the costs of CVC, diagnosis, and treatment of CRBSI) (P , .001). Article Title: From Burst to Sustained Release: The Effect of Antibiotic Structure Incorporated into Chitosan-Based Films Article Snippet: Article Title: Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy. Article Snippet: Antimicrobial-impregnated catheters are more expensive than standard catheters (S-C).. A higher incidence of catheter-related bloodstream infection (CRBSI) has been found in jugular venous access with tracheostomy than without tracheostomy.. The objective of this study was to determine central venous catheter (CVC)-related costs (considering only the cost of the CVC, diagnosis of CRBSI, and antimicrobial agents used to treat CRBSI) using rifampicin– miconazole-impregnated catheters (RM-C) or S-C in jugular venous access with tracheostomy. |